Boisenews Now

New York, USA – April 18, 2024 – The human gut microbiome plays a crucial role in maintaining overall health and has been linked to a spectrum of diseases, from metabolic disorders to autoimmune conditions. Among these, Bacteroides spp. shine as vital members of the gut microbiota, renowned for their versatile metabolic capabilities and immunomodulatory effects. Harnessing the potential of these bacteria holds great promise for pioneering new therapies across a wide range of diseases. Creative Biolabs offers specialized services tailored to Bacteroides spp., facilitating NGP discovery projects and collaborating closely with researchers to devise customized strategies and provide invaluable data for their studies.

“Bacteroides spp. are incredibly diverse and have emerged as attractive candidates for developing NGPs,” said the Chief Scientific Officer at Creative Biolabs. “We can accurately isolate and select new types of Bacteroides spp. with high affinity and specificity, equipping researchers with the powerful tools to make progress in the discovery of novel live biotherapeutics.”

Creative Biolabs offers a comprehensive suite of development services for various Bacteroides strains, aiming to accelerate research into their potential therapeutic applications.

For Bacteroides dorei, the company offers genomic analysis to identify strains with desired health benefits, alongside in vitro and in vivo efficacy testing and formulation development.

For Bacteroides fragilis, the company offers a diverse range of B. fragilis probiotic strain products tailored for research use, facilitating investigations into their therapeutic potential.

For Bacteroides thetaiotaomicron and Bacteroides vulgatus, a comprehensive suite of analytical development and qualification services such as strain isolation and identification, and functional genomics are available for researchers to have a deeper understanding of the organism’s genomic, proteomic, and metabolic profiles.

In addition to the mentioned strains, Creative Biolabs can also provide more strains to further facilitate NGP discovery.

“We are excited to make these diverse Bacteroides species accessible to the scientific community and look forward to seeing the impactful discoveries that will result from their use,” said the senior scientist at Creative Biolabs.

Researchers interested in accessing the diverse collection of Bacteroides species for NGP discovery can find more information at https://live-biotherapeutic.creative-biolabs.com.

About Creative Biolabs

Equipped with world-class technological platforms and a team of professional scientists specializing in live biotherapeutics drug discovery, Creative Biolabs is dedicated to providing comprehensive solutions for next-generation probiotic discovery. The company provides a variety of probiotic strains, from aerobic to anaerobic bacteria, catering to specific research needs worldwide.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://live-biotherapeutic.creative-biolabs.com